Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.

By S. Kaptoge, S. Seshasai, Pei Gao, D. Freitag, Adam S. Butterworth, A. Borglykke, E. di Angelantonio, V. Gudnason, A. Rumley, G. Lowe and 2 more. European Heart Journal, 2014

624 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Immunology

View Paper: https://www.semanticscholar.org/paper/2c02e1a326603fcb7dedf81ac1c898488984d847

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. Ridker
2. L. Melvin
3. Peter Libby

In Epidemiology

1. P. Ridker
2. Peter Libby
3. L. Melvin
4. G. Hansson
5. S. Grundy

In Immunology

1. P. Ridker
2. Peter Libby

Citations in the corpus

• From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection (2016, background): “trix metallopeptidase 9 (MMP-9), and lipoprotein-associated phospholipase A2 (Lp-PLA2) were also observed.(47) Thus, as”
• Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease (2019, background): “Low-grade inflammation is also a contributor to the hallmark oxidative stress associated with most cardiovascular disease [7, 100, 153], representing a cardiovascular risk factor [19] that can be targeted by pharmacological treatment [154].”